The Investment Whisperer
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

The Investment Whisperer

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024
December 20, 2024
RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation
next post
Forum Comments on Share Price

Related Posts

5 Silver Stocks With Dividends (Updated 2024)

October 31, 2024

Perpetua Gets US Forest Service Approval for Stibnite...

January 8, 2025

SAGA Metals Announces Commencement of Exploration Program by...

August 9, 2024

Editor’s Picks: Trump to Lift Minnesota Mining Ban,...

June 14, 2025

CMC Metals Ltd. Announces Share Consolidation and Name Change

March 22, 2025

Cardiol Therapeutics

February 7, 2024

Locksley Resources

September 6, 2025

Trailbreaker Resources Receives Exploration Permit for Swan Target...

May 7, 2024

Liberty Gold to Spin Out Antimony Project, Establish...

February 17, 2025

Initial Drill Results at Orom-Cross Highlight High Grade...

September 26, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (1,560)
    • Investing (4,346)
    • Politics (5,761)
    • World (4,762)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheInvestmentWhisperer.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 TheInvestmentWhisperer.com | All Rights Reserved